Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against β-amyloid.

Henderson BW, Greathouse KM, Ramdas R, Walker CK, Rao TC, Bach SV, Curtis KA, Day JJ, Mattheyses AL, Herskowitz JH.

Sci Signal. 2019 Jun 25;12(587). pii: eaaw9318. doi: 10.1126/scisignal.aaw9318.

PMID:
31239325
2.

Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study.

Zhu Y, Mordaunt CE, Yasui DH, Marathe R, Coulson RL, Dunaway KW, Jianu JM, Walker CK, Ozonoff S, Hertz-Picciotto I, Schmidt RJ, LaSalle JM.

Hum Mol Genet. 2019 Aug 15;28(16):2659-2674. doi: 10.1093/hmg/ddz084.

PMID:
31009952
3.

A Prospective Study of Environmental Exposures and Early Biomarkers in Autism Spectrum Disorder: Design, Protocols, and Preliminary Data from the MARBLES Study.

Hertz-Picciotto I, Schmidt RJ, Walker CK, Bennett DH, Oliver M, Shedd-Wise KM, LaSalle JM, Giulivi C, Puschner B, Thomas J, Roa DL, Pessah IN, Van de Water J, Tancredi DJ, Ozonoff S.

Environ Health Perspect. 2018 Nov;126(11):117004. doi: 10.1289/EHP535.

4.

Nusinersen: A Treatment for Spinal Muscular Atrophy.

Claborn MK, Stevens DL, Walker CK, Gildon BL.

Ann Pharmacother. 2019 Jan;53(1):61-69. doi: 10.1177/1060028018789956. Epub 2018 Jul 16.

PMID:
30008228
5.

Adiposity and weight gain during pregnancy associate independently with behavior of infant rhesus monkeys (Macaca mulatta).

Walker CK, VandeVoort CA, Li CS, Chaffin CL, Capitanio JP.

Dev Psychobiol. 2018 Sep;60(6):629-638. doi: 10.1002/dev.21744. Epub 2018 Jun 13.

6.

Scaling of the surface vasculature on the human placenta.

Leonard AS, Lee J, Schubert D, Croen LA, Fallin MD, Newschaffer CJ, Walker CK, Salafia CM, Morgan SP, Vvedensky DD.

Phys Rev E. 2017 Oct;96(4-1):040401. doi: 10.1103/PhysRevE.96.040401. Epub 2017 Oct 2.

7.

Substantia nigra ultrastructural pathology in schizophrenia.

Walker CK, Roche JK, Sinha V, Roberts RC.

Schizophr Res. 2018 Jul;197:209-218. doi: 10.1016/j.schres.2017.12.004. Epub 2017 Dec 21.

8.

Autism risk classification using placental chorionic surface vascular network features.

Chang JM, Zeng H, Han R, Chang YM, Shah R, Salafia CM, Newschaffer C, Miller RK, Katzman P, Moye J, Fallin M, Walker CK, Croen L.

BMC Med Inform Decis Mak. 2017 Dec 6;17(1):162. doi: 10.1186/s12911-017-0564-8.

9.

Accelerating wheat breeding for end-use quality with multi-trait genomic predictions incorporating near infrared and nuclear magnetic resonance-derived phenotypes.

Hayes BJ, Panozzo J, Walker CK, Choy AL, Kant S, Wong D, Tibbits J, Daetwyler HD, Rochfort S, Hayden MJ, Spangenberg GC.

Theor Appl Genet. 2017 Dec;130(12):2505-2519. doi: 10.1007/s00122-017-2972-7. Epub 2017 Aug 24.

PMID:
28840266
10.

Self-reported pregnancy exposures and placental DNA methylation in the MARBLES prospective autism sibling study.

Schmidt RJ, Schroeder DI, Crary-Dooley FK, Barkoski JM, Tancredi DJ, Walker CK, Ozonoff S, Hertz-Picciotto I, LaSalle JM.

Environ Epigenet. 2016 Dec;2(4). pii: dvw024. doi: 10.1093/eep/dvw024. Epub 2016 Dec 1.

11.

Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.

Walker CK, Sandmann EA, Horyna TJ, Gales MA.

Ann Pharmacother. 2017 Apr;51(4):323-331. doi: 10.1177/1060028016683970. Epub 2016 Dec 15. Review.

PMID:
28228055
12.

Placental methylome analysis from a prospective autism study.

Schroeder DI, Schmidt RJ, Crary-Dooley FK, Walker CK, Ozonoff S, Tancredi DJ, Hertz-Picciotto I, LaSalle JM.

Mol Autism. 2016 Dec 15;7:51. doi: 10.1186/s13229-016-0114-8. eCollection 2016.

13.

Meconium exposure and autism risk.

Miller KM, Xing G, Walker CK.

J Perinatol. 2017 Feb;37(2):203-207. doi: 10.1038/jp.2016.200. Epub 2016 Nov 3.

14.

Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.

Randolph LA, Walker CK, Nguyen AT, Zachariah SR.

J Oncol Pharm Pract. 2018 Jan;24(1):3-8. doi: 10.1177/1078155216671189. Epub 2016 Sep 27.

PMID:
27682600
15.

Melatonin Receptor Agonists for Delirium Prevention.

Walker CK, Gales MA.

Ann Pharmacother. 2017 Jan;51(1):72-78. doi: 10.1177/1060028016665863. Epub 2016 Aug 20. Review.

PMID:
27539735
16.

Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions.

Krakowiak P, Walker CK, Tancredi D, Hertz-Picciotto I, Van de Water J.

Autism Res. 2017 Jan;10(1):89-98. doi: 10.1002/aur.1657. Epub 2016 Jun 17.

17.

The National Children's Study: Recruitment Outcomes Using the Provider-Based Recruitment Approach.

Hale DE, Wyatt SB, Buka S, Cherry D, Cislo KK, Dudley DJ, McElfish PA, Norman GS, Reynolds SA, Siega-Riz AM, Wadlinger S, Walker CK, Robbins JM.

Pediatrics. 2016 Jun;137 Suppl 4:S239-47. doi: 10.1542/peds.2015-4410E.

18.

Preeclampsia, placental insufficiency, autism, and antiphospholipid antibodies-reply.

Walker CK, Ashwood P, Hertz-Picciotto I.

JAMA Pediatr. 2015 Jun;169(6):606-7. doi: 10.1001/jamapediatrics.2015.0345. No abstract available.

19.

A descriptive and historical review of bibliometrics with applications to medical sciences.

Thompson DF, Walker CK.

Pharmacotherapy. 2015 Jun;35(6):551-9. doi: 10.1002/phar.1586. Epub 2015 May 4.

PMID:
25940769
20.

Elevated Excitatory Input to the Nucleus Accumbens in Schizophrenia: A Postmortem Ultrastructural Study.

McCollum LA, Walker CK, Roche JK, Roberts RC.

Schizophr Bull. 2015 Sep;41(5):1123-32. doi: 10.1093/schbul/sbv030. Epub 2015 Mar 27.

21.

Maternal Recall Versus Medical Records of Metabolic Conditions from the Prenatal Period: A Validation Study.

Krakowiak P, Walker CK, Tancredi DJ, Hertz-Picciotto I.

Matern Child Health J. 2015 Sep;19(9):1925-35. doi: 10.1007/s10995-015-1723-0.

22.

Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay.

Walker CK, Krakowiak P, Baker A, Hansen RL, Ozonoff S, Hertz-Picciotto I.

JAMA Pediatr. 2015 Feb;169(2):154-62. doi: 10.1001/jamapediatrics.2014.2645.

23.

Infertility and its treatments in association with autism spectrum disorders: a review and results from the CHARGE study.

Lyall K, Baker A, Hertz-Picciotto I, Walker CK.

Int J Environ Res Public Health. 2013 Aug 19;10(8):3715-34. doi: 10.3390/ijerph10083715. Review.

24.

The detection of QTLs in barley associated with endosperm hardness, grain density, grain size and malting quality using rapid phenotyping tools.

Walker CK, Ford R, Muñoz-Amatriaín M, Panozzo JF.

Theor Appl Genet. 2013 Oct;126(10):2533-51. doi: 10.1007/s00122-013-2153-2. Epub 2013 Jul 25.

PMID:
23884598
25.

Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism.

Walker CK, Anderson KW, Milano KM, Ye S, Tancredi DJ, Pessah IN, Hertz-Picciotto I, Kliman HJ.

Biol Psychiatry. 2013 Aug 1;74(3):204-11. doi: 10.1016/j.biopsych.2013.03.006. Epub 2013 Apr 25.

26.

Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice.

Koenig CM, Walker CK, Qi L, Pessah IN, Berman RF.

PLoS One. 2012;7(6):e38911. doi: 10.1371/journal.pone.0038911. Epub 2012 Jun 13.

27.

Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders.

Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, Hansen RL, Hertz-Picciotto I.

Pediatrics. 2012 May;129(5):e1121-8. doi: 10.1542/peds.2011-2583. Epub 2012 Apr 9.

28.

Autism risk in small- and large-for-gestational-age infants.

Moore GS, Kneitel AW, Walker CK, Gilbert WM, Xing G.

Am J Obstet Gynecol. 2012 Apr;206(4):314.e1-9. doi: 10.1016/j.ajog.2012.01.044.

PMID:
22464070
29.

Increasing pre-pregnancy body mass index is predictive of a progressive escalation in adverse pregnancy outcomes.

Chung JH, Melsop KA, Gilbert WM, Caughey AB, Walker CK, Main EK.

J Matern Fetal Neonatal Med. 2012 Sep;25(9):1635-9. doi: 10.3109/14767058.2011.648970. Epub 2012 Jan 30.

PMID:
22185383
30.

Gonorrhea infection in women: prevalence, effects, screening, and management.

Walker CK, Sweet RL.

Int J Womens Health. 2011;3:197-206. doi: 10.2147/IJWH.S13427. Epub 2011 Jul 19.

31.

Chromosomal loci associated with endosperm hardness in a malting barley cross.

Walker CK, Panozzo JF, Ford R, Eckermann P, Moody D, Lehmensiek A, Appels R.

Theor Appl Genet. 2011 Jan;122(1):151-62. doi: 10.1007/s00122-010-1431-5. Epub 2010 Sep 10.

PMID:
20830465
32.
33.

Association between maternal obesity and fetal cardiac malformations in African Americans.

Mikhail LN, Walker CK, Mittendorf R.

J Natl Med Assoc. 2002 Aug;94(8):695-700.

34.

Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis).

Peipert JF, Sweet RL, Walker CK, Kahn J, Rielly-Gauvin K.

Infect Dis Obstet Gynecol. 1999;7(3):138-44.

35.

Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases.

Walker CK, Workowski KA, Washington AE, Soper D, Sweet RL.

Clin Infect Dis. 1999 Jan;28 Suppl 1:S29-36. Review.

PMID:
10028108
36.

Preeclampsia. A nested, case-control study of risk factors and their interactions.

Mittendorf R, Lain KY, Williams MA, Walker CK.

J Reprod Med. 1996 Jul;41(7):491-6.

PMID:
8829061
37.

Human fetal antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.

Landers DV, Smith JP, Walker CK, Milam T, Sanchez-Pescador L, Kohl S.

Pediatr Res. 1994 Mar;35(3):289-92.

PMID:
8190515
38.

Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy.

Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL.

J Infect Dis. 1993 Oct;168(4):969-78.

PMID:
8376843
39.

Comparison of rapid tests for detection of group B streptococcal colonization.

Walker CK, Crombleholme WR, Ohm-Smith MJ, Sweet RL.

Am J Perinatol. 1992 Jul;9(4):304-8.

PMID:
1627226
40.

Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model.

Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL.

JAMA. 1991 Nov 13;266(18):2594-604. Review.

PMID:
1834868
41.

Pelvic inflammatory disease. Key treatment issues and options.

Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S.

JAMA. 1991 Nov 13;266(18):2605-11. Review.

PMID:
1658404
42.

Anti-infective drugs in obstetrics and gynecology.

Walker CK, Landers DV.

Curr Opin Obstet Gynecol. 1991 Oct;3(5):698-706. Review.

PMID:
1958804
43.

Pelvic abscesses: new trends in management.

Walker CK, Landers DV.

Obstet Gynecol Surv. 1991 Sep;46(9):615-24. Review. No abstract available.

PMID:
1836057
44.

Stressed to kill.

Walker CK.

Bus Health. 1991 Sep;9(9):42, 44-5, 47 passim.

PMID:
10112860
45.

Healthy babies for healthy companies.

Walker CK.

Bus Health. 1991 May;9(5):29-30, 34-5. No abstract available.

PMID:
10110525
46.

Comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline in the inpatient treatment of acute salpingitis.

Walker CK, Landers DV, Ohm-Smith MJ, Robbie MO, Luft J, Schachter J, Sweet RL.

Sex Transm Dis. 1991 Apr-Jun;18(2):119-23.

PMID:
1862460
47.

Vision care benefits boom.

Walker CK.

Bus Health. 1990 Nov;[vision]:6-9. No abstract available.

PMID:
10107785
48.

Choosing a vision care provider.

Walker CK.

Bus Health. 1990 Nov;[vision]:12-3. No abstract available.

PMID:
10107784
49.

Efficacy of the dentin bonding agents. Part II. A comparison of glass ionomer cement with dentin bonding agents.

Leinfelder KF, Russell CM, Thornton RJ, Cowen RG, Walker CK.

J Ala Dent Assoc. 1986 Spring;70(2):15-22. No abstract available.

PMID:
3519722
50.

Efficacy of the dentin bonding agents. Part I. Their effectiveness in reducing microleakage.

Leinfelder KF, Russell CM, Thornton RJ, Cowen RG, Walker CK.

J Ala Dent Assoc. 1986 Winter;70(1):13-20. No abstract available.

PMID:
3514720

Supplemental Content

Loading ...
Support Center